The effects of critical/acute illness on the human microbiota are already well known, given the need - in many cases - for the use of broad-spectrum antibiotics.

In recent years, there has been increasing awareness of the prognostic value of skeletal muscle changes in chronic diseases, and a multimodal approach is considered the best option for treating muscle loss.